Naoyuki Maeda
- Oncology top 10%
- HER2/EGFR in Cancer Research 5
-
- Hormonal and reproductive studies 12
- Growth Hormone and Insulin-like Growth Factors 5
-
- Estrogen and related hormone effects 6
- Digestive system and related health 4
-
- Effects and risks of endocrine disrupting chemicals 5
-
- Meat and Animal Product Quality 4
-
- Cardiomyopathy and Myosin Studies 4
In The Last Decade
Naoyuki Maeda
56 papers receiving 697 citations
Peers
Comparison fields: 5 of 85
- Oncology 237
- Behavioral Neuroscience 22
- Radiology, Nuclear Medicine and Imaging 122
- Endocrinology, Diabetes and Metabolism 79
- Molecular Biology 280
Countries citing papers authored by Naoyuki Maeda
This map shows the geographic impact of Naoyuki Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoyuki Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoyuki Maeda more than expected).
Fields of papers citing papers by Naoyuki Maeda
This network shows the impact of papers produced by Naoyuki Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoyuki Maeda. The network helps show where Naoyuki Maeda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naoyuki Maeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 5 | |
| 9 | 2021 | 5 | |
| 10 | 2021 | 11 | |
| 11 | 2020 | 6 | |
| 12 | 2019 | 59 | |
| 13 | 2018 | 8 | |
| 14 | 2017 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2015 | 8 | |
| 17 | 2012 | 35 | |
| 18 | 2010 | 11 | |
| 19 | 2006 | 46 | |
| 20 | 2006 | 15 |
About Naoyuki Maeda
Naoyuki Maeda is a scholar working on Endocrinology, Diabetes and Metabolism, Animal Science and Zoology and Behavioral Neuroscience, having authored 59 papers that have together received 713 indexed citations. Recurring topics across this work include Hormonal and reproductive studies (12 papers), Estrogen and related hormone effects (6 papers), Growth Hormone and Insulin-like Growth Factors (5 papers), HER2/EGFR in Cancer Research (5 papers), Effects and risks of endocrine disrupting chemicals (5 papers), Meat and Animal Product Quality (4 papers), Digestive system and related health (4 papers) and Cardiomyopathy and Myosin Studies (4 papers). The work is most often cited by research in Oncology (237 citations), Behavioral Neuroscience (22 citations) and Radiology, Nuclear Medicine and Imaging (122 citations). Naoyuki Maeda has collaborated with scholars based in Japan, Germany and Russia. Frequent co-authors include Kenji Hirotani, Hiroshi Yokota, Takashi Kagari, Taku Miyasho, Hisato Kawakami, Kimio Yonesaka, Kazuto Nishio, Tomohito Iwasaki, Koji Haratani and Kazuhiko Nakagawa. Their work appears in journals such as Steroids, PLoS ONE, Molecular and Cellular Endocrinology, Journal of the Science of Food and Agriculture and Animal Science Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.